Operating Lease, Weighted Average Discount Rate, Percent in pure of Cyclacel Pharmaceuticals, Inc. from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent history and change rate from Q1 2019 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 30 Sep 2024 was 0.12 pure, unchanged year-over-year.
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

Cyclacel Pharmaceuticals, Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 0.12 0 0% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 0.12 0 0% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 0.12 0 0% 31 Mar 2024 10-Q 14 May 2024
Q3 2023 0.12 30 Sep 2023 10-Q 29 Nov 2023
Q2 2023 0.12 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 0.12 0 0% 31 Mar 2023 10-Q 11 May 2023
Q1 2022 0.12 0 0% 31 Mar 2022 10-Q 12 May 2022
Q3 2021 0.12 0 0% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 0.12 0 0% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 0.12 0 0% 31 Mar 2021 10-Q 14 May 2021
Q3 2020 0.12 0 0% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 0.12 0 0% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 0.12 0 0% 31 Mar 2020 10-Q 12 May 2020
Q3 2019 0.12 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 0.12 30 Jun 2019 10-Q 13 Aug 2019
Q1 2019 0.12 31 Mar 2019 10-Q 14 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.